The Glenway Health Plan's pharmacy and therapeutics (P&T) committee conducted pharmacoeconomic research to measure both the clinical outcomes and costs of two new cholesterol-reducing drugs. Results were presented as a ratio showing the cost required to produce a 1 mcg/l decrease in cholesterol levels. The type of pharmacoeconomic research that Glenway conducted in this situation was most likely
Catalina
8 months agoSina
8 months agoBeckie
8 months agoJulio
8 months agoSol
8 months agoIzetta
9 months agoLettie
9 months agoAllene
9 months ago